medigraphic.com
SPANISH

Acta Médica del Centro

ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 3

<< Back Next >>

Acta Med Cent 2015; 9 (3)

Esteatosis hepática focal multinodular. Presentación de una paciente

Martínez-Fortún AM, Cabrera AD, Pozo SMC
Full text How to cite this article

Language: Spanish
References: 10
Page: 53-57
PDF size: 237.86 Kb.


Key words:

non-alcoholic fatty liver disease, ultrasonography.

ABSTRACT

The hepatic disease or liver fatty non alcoholic consists on the appearance of changes for fatty infiltration in the liver that are not related to alcohol consumption. This condition encompasses a wide ranging of hepatic damages including from simple hepatic steatosis to steatohepatitis or cirrhosis. Ii is presented a female patient of 42 years old that in ultrasound control made she showed multiple hepatic hyperechoic nodular images; she was studied with on-line axial tomography and histo-pathologically and fat nature of nodular images were confirmed. Hepatic steatosis is a disease very common and well characterized by imaging methods, it has patterns of different reservoir and in some cases for accurate diagnosis it is necessary a biopsy of the affected tissue which, in this case, was made by laparoscopy.


REFERENCES

  1. Turkish AR. Nonalcoholic fatty liver disease: emerging mechanisms and consequences. Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):128-33.

  2. Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus. Endocr Res. 2007;32(3):59-69.

  3. Musso G, Gambino R, Cassader M. A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease. Hepatology. 2010;52:79-104. doi: 10.1002/hep.23623.

  4. Córdova Pluma VH. Hígado graso no alcohólico: un encuadre didáctico para un problema latente. Segunda parte. Med Int Mex. 2009;25(2):129-53.

  5. Vanni E, Bugianesi E, Kotronen A. From the metabolic to NAFLD o vice versa? Dig Liver Dis 2010;42:320-30.

  6. Feldstedin AE, Wieckowska A, López A. Cytokeratins -18 fragment for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2013;50:1072-78.

  7. Chavez-Tapia NC, Uribe M, Ponciano-Rodriguez G, Medina-Satillan R, Mendez-Sanchez N. New Insights into the pathophysiology of non-alcoholic fatty liver. Ann Hepatol. 2009;8(1):S9-S17.

  8. Tilg H, Moschen A. Evolution of inflammation in Non alcoholic Fatty Liver Disease: The multiple Parallel Hits Hypothesis. Hepatology. 2010;52:1836-46.

  9. Estep JM, Bererdinc A, Younossi Z. Non-Invasive Diagnosatic Test forNon-Alcoholic Fatty Liver Disease 2010. Cur Mol Med. 2010;10:166-72.

  10. 10.10.Ratziu V, Bellenteni S, Cortez-Pinto DC, Marchesini G. A position statement on NAFLD|NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372-84.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med Cent. 2015;9